A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors

Published:2009-09-01 Issue:18 Volume:15 Page:5910-5916
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Demetri George D.,Casali Paolo G.,Blay Jean-Yves,von Mehren Margaret,Morgan Jeffrey A.,Bertulli Rossella,Ray-Coquard Isabelle,Cassier Philippe,Davey Monica,Borghaei Hossein,Pink Daniel,Debiec-Rychter Maria,Cheung Wing,Bailey Stuart M.,Veronese Maria Luisa,Reichardt Annette,Fumagalli Elena,Reichardt Peter

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022;Journal of the National Comprehensive Cancer Network;2022-11

2. Efficacy evaluation of nilotinib treatment in different genomic subtypes of gastrointestinal stromal tumors: A meta-analysis and systematic review;Current Problems in Cancer;2021-06

3. Gastrointestinal stromal tumor: a review of current and emerging therapies;Cancer and Metastasis Reviews;2021-04-19

4. Allosteric Inhibition of ABL Kinases: Therapeutic Potential in Cancer;Molecular Cancer Therapeutics;2020-06-30

5. Preparation and Characterization of a Novel Swellable and Floating Gastroretentive Drug Delivery System (sfGRDDS) for Enhanced Oral Bioavailability of Nilotinib;Pharmaceutics;2020-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP